Attività
Dirigenti
Dirigenti | Titolo | Età | Da |
---|---|---|---|
Chief Executive Officer | 39 | 01/05/14 | |
President | - | - | |
Anthony Sireci
CTO | Chief Tech/Sci/R&D Officer | - | - |
Chief Tech/Sci/R&D Officer | - | - | |
Liz Beja
COO | Chief Operating Officer | - | - |
David Hyman
CTO | Chief Tech/Sci/R&D Officer | - | 01/01/20 |
Compliance Officer | - | 01/04/18 | |
Human Resources Officer | - | - | |
Amy Rose
HRO | Human Resources Officer | - | 01/01/20 |
Philip Johnson
LAW | General Counsel | - | 01/11/20 |
Classe di azioni
Voto | Quantità | Flottante | Autocontrollo | Flottante totale | |
---|---|---|---|---|---|
Azione A | 1 | 30 614 536 | 29 481 314 ( 96,30 %) | 0 | 96,30 % |
Coordinate società
Loxo Oncology, Inc.
281 Tresser Boulevard 9th floor
06901, Stamford
+203-653-3880
http://www.loxooncology.com![Indirizzo Loxo Oncology Inc](https://cdn.zonebourse.com/static/address/17068136.png)
Settore
Variaz. 1 gen. | Capi. | |
---|---|---|
+20,63% | 126 Mrd | |
+24,16% | 27,95 Mrd | |
-20,17% | 20,5 Mrd | |
-16,06% | 17,12 Mrd | |
-18,07% | 16,1 Mrd | |
-47,70% | 14,97 Mrd | |
+11,92% | 14,84 Mrd | |
+58,32% | 14,38 Mrd | |
+149,98% | 12,37 Mrd |